Columbus, Ohio
Phase 1 cancer trials in Columbus, OH
86 Phase 1 cancer studies are recruiting participants at sites in Columbus as of November 17, 2026, according to ClinicalTrials.gov. Phase 1 Cancer Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Columbus at a glance
- 86 studies are recruiting at a site in Columbus.
- By phase: Early Phase 1 (4), Phase 1 (39), Phase 1/2 (43).
- By sponsor: industry (54), university, hospital or other (25), government (7).
- By research area: Lymphoma (33), Breast Cancer (20), Lung Cancer (20), Prostate Cancer (6), Pancreatic Cancer (4), Melanoma (3).
- Most recent update to one of these records: November 17, 2026.
Breast cancer studies recruiting in Columbus
Basic details from each study's public record (the 30 most recently updated of 86). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05422794 · updated
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
- Phase 1
- Ages 18 to 55
- Female participants
- Sponsor
- TerSera Therapeutics LLC
- Study site
- The Mark H. Zangmeister Center-Mid Ohio Oncology/Hematology, Inc.
- Registry record
- NCT07310420 · updated
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT03424005 · updated
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Genmab
- Study site
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute
- Registry record
- NCT05579366 · updated
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The Ohio State University (OSU) Wexner Medical Center
- Registry record
- NCT06400472 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Lung cancer studies recruiting in Columbus
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06287775 · updated
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SystImmune Inc.
- Study site
- Ohio State University
- Registry record
- NCT07080242 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- The Jame Outpatient Care West Campus
- Registry record
- NCT07397338 · updated
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Gilead Sciences
- Study site
- Ohio State University CRS
- Registry record
- NCT06303505 · updated
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0015)
- Registry record
- NCT04165070 · updated
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Synthekine
- Study site
- The James Cancer Hospital and Solove Research Institute
- Registry record
- NCT05098132 · updated
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AbbVie
- Study site
- The Mark H Zangmeister Center /ID# 272502
- Registry record
- NCT06772623 · updated
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Tango Therapeutics, Inc.
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06810544 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Prostate cancer studies recruiting in Columbus
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Regeneron Pharmaceuticals
- Study site
- James Cancer Hospital and Solove Research Institute
- Registry record
- NCT03972657 · updated
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- Phase 1
- Ages 18 to 100
- Male participants
- Sponsor
- Janux Therapeutics
- Study site
- The Ohio State University
- Registry record
- NCT05519449 · updated
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
- Phase 1
- Ages 18 and older
- Male participants
- Sponsor
- K36 Therapeutics, Inc.
- Study site
- The Ohio State University Comprehensive Cancer Center
- Registry record
- NCT07103018 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Lymphoma studies recruiting in Columbus
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Study site
- Nationwide Children's Hospital
- Registry record
- NCT04726241 · updated
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- John Reneau
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT04848064 · updated
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT04301076 · updated
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- Nuvalent Inc.
- Study site
- OSU Brain & Spine Hospital
- Registry record
- NCT05384626 · updated
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- The James Cancer Hospital and Solove Research Institute
- Registry record
- NCT05091424 · updated
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Study site
- The Ohio State University (OSU)
- Registry record
- NCT07226843 · updated
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Veronika Bachanova
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT03681561 · updated
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Early Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- AIDS Malignancy Consortium
- Study site
- The Ohio State University
- Registry record
- NCT04139304 · updated
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- AstraZeneca
- Registry record
- NCT06564038 · updated
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Phase 1/2
- Ages 13 to 90
- All sexes
- Sponsor
- Vironexis Biotherapeutics Inc.
- Study site
- The Ohio State University Wexner Medical Center
- Registry record
- NCT06533579 · updated
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT06860594 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Columbus, OH on ClinicalTrials.gov.
Pancreatic cancer studies recruiting in Columbus
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Study site
- Ohio State University Comprehensive Cancer Center
- Registry record
- NCT05372614 · updated
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- RayzeBio, Inc.
- Registry record
- NCT07165132 · updated
Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Phase 1/2
- Ages 18 to 90
- All sexes
- Sponsor
- Perspective Therapeutics
- Study site
- Ohio State University
- Registry record
- NCT06710756 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Columbus, OH on ClinicalTrials.gov.
Ask about studies near Columbus
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Ohio
All Ohio locations
194 studies recruiting across 12 cities.
Cleveland
78 studies recruiting.
Cincinnati
38 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Phase 1 Cancer Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections